The German Association of Statutory Health Insurance Funds (GKV) has issued a stark warning to the ruling coalition, urging lawmakers not to weaken a major savings package scheduled for a parliamentary vote next week. The package, designed to address a projected financial shortfall of 18.8 billion euros in the statutory health insurance system, faces mounting pressure from industry groups and patient advocates seeking to soften its impact.
Oliver Blatt, the head of the GKV, told the Neue Osnabrücker Zeitung that there is intense debate about whether planned cuts to pharmaceutical industry reimbursements and physician payments should be scaled back. He also expressed concern that the broader hospital reform could be watered down. “That would be exactly the wrong approach, because in the end it will once again become more expensive for everyone,” Blatt said.
The savings package, which the Bundestag is expected to pass next week, aims to relieve statutory health insurers from rapidly rising costs by 2027. Without decisive and comprehensive reforms, Blatt warned, further increases in contribution rates would be unavoidable. He highlighted that in the first months of this year, health insurance expenditures have risen twice as fast as revenues. “If we do not act quickly and decisively, our finances will blow up in our faces at the turn of the year,” he cautioned.
Under the proposed measures, increases in compensation for doctors’ practices, hospitals, and the pharmaceutical sector would be capped. Patients would face higher co-payments for medications and restrictions on the free co-insurance of spouses. The package is intended to close an expected funding gap of 18.8 billion euros for the coming year, though details are still being negotiated.
The plans have drawn sharp criticism from various stakeholders. Physicians’ associations have warned that they may be forced to reduce their range of services. Patient representatives and the pharmaceutical industry have also voiced strong objections. Blatt, however, called on the Bundestag to resist what he described as lobbying pressure from the pharmaceutical industry, hospitals, and doctors. He argued that insured individuals and employers have already made more than a fair contribution to the financing and savings plans, pointing to recent increases in supplementary contribution rates, as well as planned hikes in co-payments and the contribution assessment ceiling.
The GKV’s warning comes at a critical juncture as the coalition government, composed of the Christian Democratic Union (CDU), its Bavarian sister party the Christian Social Union (CSU), and the Social Democratic Party (SPD), seeks to finalize the legislation. The outcome of next week’s vote will have significant implications for the financial stability of Germany’s statutory health insurance system, which covers about 90 percent of the population.
If the package is diluted, Blatt warned, the financial pressures on the system could lead to a cycle of rising contributions and reduced benefits, ultimately affecting the quality of care for millions of patients. The debate underscores the broader challenges facing Germany’s healthcare system, which is grappling with demographic change, rising costs, and the need for structural reforms.